1.1 Research Scope 1.2 Market Segmentation 1.3 Research Objectives 1.4 Research Methodology 1.4.1 Research Process 1.4.2 Data Triangulation 1.4.3 Research Approach 1.4.4 Base Year 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections 1.5.2 Covid-19 Impact: Commodity Prices Indices 1.5.3 Covid-19 Impact: Global Major Government Policy 1.6 The Covid-19 Impact on Daptomycin Industry 1.7 COVID-19 Impact: Daptomycin Market Trends 2 Global Daptomycin Quarterly Market Size Analysis 2.1 Daptomycin Business Impact Assessment - COVID-19 2.1.1 Global Daptomycin Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 2.1.2 Global Daptomycin Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 2.2 Global Daptomycin Quarterly Market Size 2020-2021 2.3 COVID-19-Driven Market Dynamics and Factor Analysis 2.3.1 Drivers 2.3.2 Restraints 2.3.3 Opportunities 2.3.4 Challenges 3 Quarterly Competitive Assessment, 2020 3.1 Global Daptomycin Quarterly Market Size by Manufacturers, 2019 VS 2020 3.2 Global Daptomycin Factory Price by Manufacturers 3.3 Location of Key Manufacturers Daptomycin Manufacturing Factories and Area Served 3.4 Date of Key Manufacturers Enter into Daptomycin Market 3.5 Key Manufacturers Daptomycin Product Offered 3.6 Mergers & Acquisitions, Expansion Plans 4 Impact of Covid-19 on Daptomycin Segments, By Type 4.1 Introduction 1.4.1 350 mg lyophilized powder 1.4.2 500 mg lyophilized powder 4.2 By Type, Global Daptomycin Market Size, 2019-2021 4.2.1 By Type, Global Daptomycin Market Size by Type, 2020-2021 4.2.2 By Type, Global Daptomycin Price, 2020-2021 5 Impact of Covid-19 on Daptomycin Segments, By Application 5.1 Overview 5.5.1 Adult 5.5.2 Pediatric patients (1 to 17 years of age) 5.2 By Application, Global Daptomycin Market Size, 2019-2021 5.2.1 By Application, Global Daptomycin Market Size by Application, 2019-2021 5.2.2 By Application, Global Daptomycin Price, 2020-2021 6 Geographic Analysis 6.1 Introduction 6.2 North America 6.2.1 Macroeconomic Indicators of US 6.2.2 US 6.2.3 Canada 6.3 Europe 6.3.1 Macroeconomic Indicators of Europe 6.3.2 Germany 6.3.3 France 6.3.4 UK 6.3.5 Italy 6.4 Asia-Pacific 6.4.1 Macroeconomic Indicators of Asia-Pacific 6.4.2 China 6.4.3 Japan 6.4.4 South Korea 6.4.5 India 6.4.6 ASEAN 6.5 Rest of World 6.5.1 Latin America 6.5.2 Middle East and Africa 7 Company Profiles 7.1 Merck & Co. 7.1.1 Merck & Co. Business Overview 7.1.2 Merck & Co. Daptomycin Quarterly Production and Revenue, 2020 7.1.3 Merck & Co. Daptomycin Product Introduction 7.1.4 Merck & Co. Response to COVID-19 and Related Developments 7.2 Pfizer 7.2.1 Pfizer Business Overview 7.2.2 Pfizer Daptomycin Quarterly Production and Revenue, 2020 7.2.3 Pfizer Daptomycin Product Introduction 7.2.4 Pfizer Response to COVID-19 and Related Developments 7.3 Teva 7.3.1 Teva Business Overview 7.3.2 Teva Daptomycin Quarterly Production and Revenue, 2020 7.3.3 Teva Daptomycin Product Introduction 7.3.4 Teva Response to COVID-19 and Related Developments 7.4 Mylan 7.4.1 Mylan Business Overview 7.4.2 Mylan Daptomycin Quarterly Production and Revenue, 2020 7.4.3 Mylan Daptomycin Product Introduction 7.4.4 Mylan Response to COVID-19 and Related Developments 7.5 Fresenius Kabi 7.5.1 Fresenius Kabi Business Overview 7.5.2 Fresenius Kabi Daptomycin Quarterly Production and Revenue, 2020 7.5.3 Fresenius Kabi Daptomycin Product Introduction 7.5.4 Fresenius Kabi Response to COVID-19 and Related Developments 7.6 Sagent Pharmaceuticals 7.6.1 Sagent Pharmaceuticals Business Overview 7.6.2 Sagent Pharmaceuticals Daptomycin Quarterly Production and Revenue, 2020 7.6.3 Sagent Pharmaceuticals Daptomycin Product Introduction 7.6.4 Sagent Pharmaceuticals Response to COVID-19 and Related Developments 7.7 Xellia 7.7.1 Xellia Business Overview 7.7.2 Xellia Daptomycin Quarterly Production and Revenue, 2020 7.7.3 Xellia Daptomycin Product Introduction 7.7.4 Xellia Response to COVID-19 and Related Developments 7.8 Hisun 7.8.1 Hisun Business Overview 7.8.2 Hisun Daptomycin Quarterly Production and Revenue, 2020 7.8.3 Hisun Daptomycin Product Introduction 7.8.4 Hisun Response to COVID-19 and Related Developments 7.9 HENGRUI PHARMA 7.9.1 HENGRUI PHARMA Business Overview 7.9.2 HENGRUI PHARMA Daptomycin Quarterly Production and Revenue, 2020 7.9.3 HENGRUI PHARMA Daptomycin Product Introduction 7.9.4 HENGRUI PHARMA Response to COVID-19 and Related Developments 7.10 Huadong Medicine 7.10.1 Huadong Medicine Business Overview 7.10.2 Huadong Medicine Daptomycin Quarterly Production and Revenue, 2020 7.10.3 Huadong Medicine Daptomycin Product Introduction 7.10.4 Huadong Medicine Response to COVID-19 and Related Developments 8 Supply Chain and Sales Channels Analysis 8.1 Daptomycin Supply Chain Analysis 8.1.1 Daptomycin Supply Chain Analysis 8.1.2 Covid-19 Impact on Daptomycin Supply Chain 8.2 Distribution Channels Analysis 8.2.1 Daptomycin Distribution Channels 8.2.2 Covid-19 Impact on Daptomycin Distribution Channels 8.2.3 Daptomycin Distributors 8.3 Daptomycin Customers 9 Key Findings 10 Appendix 10.1 About Us 10.2 Disclaimer

List of Tables Table 1. Overview of the World Economic Outlook Projections Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity) Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 7. Covid-19 Impact: Global Major Government Policy Table 8. The Covid-19 Impact on Daptomycin Assessment Table 9. COVID-19 Impact: Daptomycin Market Trends Table 10. COVID-19 Impact Global Daptomycin Market Size Table 11. Global Daptomycin Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K MT) Table 12. Global Daptomycin Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/MT) Table 13. Global Daptomycin Quarterly Market Size, 2020 (US$ Million) & (K MT) Table 14. Global Daptomycin Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million) Table 15. Global Daptomycin Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K MT) Table 16. Global Daptomycin Market Growth Drivers Table 17. Global Daptomycin Market Restraints Table 18. Global Daptomycin Market Opportunities Table 19. Global Daptomycin Market Challenges Table 20. Key Manufacturers Daptomycin Quarterly Revenue, 2019 VS 2020 (US$ Million) Table 21. Top Manufacturers, Daptomycin Market Size, 2019 (K MT) & (US$ Million) Table 22. Daptomycin Factory Price by Manufacturers 2020 (USD/MT) Table 23. Location of Key Manufacturers Daptomycin Manufacturing Plants Table 24. Key Manufacturers Daptomycin Market Served Table 25. Date of Key Manufacturers Enter into Daptomycin Market Table 26. Key Manufacturers Daptomycin Product Type Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Daptomycin Market Size by Type, 2020, (US$ Million) Table 29. Global Daptomycin Market Size by Type, 2020 (K MT) Table 30. Global Daptomycin Price: by Type, 2020-2021 (USD/MT) Table 31. Global Daptomycin Market Size by Application: 2020-2021 (US$ Million) Table 32. Global Daptomycin Market Size by Application, 2020-2021 (K MT) Table 33. Global Daptomycin Price: by Application, 2020-2021 (USD/MT) Table 34. Global Daptomycin Market Size by Region, 2019-2021 (US$ Million) Table 35. Global Daptomycin Market Size by Region, 2019-2021 (K MT) Table 36. By Country, North America Daptomycin Market Size, 2019-2021 (US$ Million) Table 37. By Country, North America Daptomycin Market Size, 2019-2021 (K MT) Table 38. US Daptomycin Market Size, 2019-2021 (US$ Million) & (K MT) Table 39. Canada Daptomycin Market Size, 2019-2021 (US$ Million) & (K MT) Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy) Table 41. By Country, Europe Daptomycin Market Size, 2019-2021 (US$ Million) Table 42. By Country, Europe Daptomycin Market Size, 2019-2021 (K MT) Table 43. Germany Daptomycin Market Size, 2019-2021 (US$ Million) & (K MT) Table 44. France Daptomycin Market Size, 2019-2021 (US$ Million) & (K MT) Table 45. UK Daptomycin Market Size, 2019-2021 (US$ Million) & (K MT) Table 46. Italy Daptomycin Market Size, 2019-2021 (US$ Million) & (K MT) Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN) Table 48. By Region, Asia-Pacific Daptomycin Market Size, 2019-2021 (US$ Million) Table 49. By Region, Asia-Pacific Daptomycin Market Size, 2019-2021 (K MT) Table 50. China Daptomycin Market Size, 2019-2021 (US$ Million) & (K MT) Table 51. Japan Daptomycin Market Size, 2019-2021 (US$ Million) & (K MT) Table 52. South Korea Daptomycin Market Size, 2019-2021 (US$ Million) & (K MT) Table 53. India Daptomycin Market Size, 2019-2021 (US$ Million) & (K MT) Table 54. ASEAN Daptomycin Market Size, 2019-2021 (US$ Million) & (K MT) Table 55. Latin America Daptomycin Market Size, 2019-2021 (US$ Million) & (K MT) Table 56. Middle East and Africa Daptomycin Market Size, 2019-2021 (US$ Million) & (K MT) Table 57. Merck & Co. Business Overview Table 58. Merck & Co. Daptomycin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 59. Merck & Co. Daptomycin Product Table 60. Merck & Co. Response to COVID-19 and Related Developments Table 61. Pfizer Business Overview Table 62. Pfizer Daptomycin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 63. Pfizer Daptomycin Product Table 64. Pfizer Response to COVID-19 and Related Developments Table 65. Teva Business Overview Table 66. Teva Daptomycin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 67. Teva Daptomycin Product Table 68. Teva Response to COVID-19 and Related Developments Table 69. Mylan Business Overview Table 70. Mylan Daptomycin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 71. Mylan Daptomycin Product Table 72. Mylan Response to COVID-19 and Related Developments Table 73. Fresenius Kabi Business Overview Table 74. Fresenius Kabi Daptomycin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 75. Fresenius Kabi Daptomycin Product Table 76. Fresenius Kabi Response to COVID-19 and Related Developments Table 77. Sagent Pharmaceuticals Business Overview Table 78. Sagent Pharmaceuticals Daptomycin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 79. Sagent Pharmaceuticals Daptomycin Product Table 80. Sagent Pharmaceuticals Response to COVID-19 and Related Developments Table 81. Xellia Business Overview Table 82. Xellia Daptomycin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 83. Xellia Daptomycin Product Table 84. Xellia Response to COVID-19 and Related Developments Table 85. Hisun Business Overview Table 86. Hisun Daptomycin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 87. Hisun Daptomycin Product Table 88. Hisun Response to COVID-19 and Related Developments Table 89. HENGRUI PHARMA Business Overview Table 90. HENGRUI PHARMA Daptomycin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 91. HENGRUI PHARMA Daptomycin Product Table 92. HENGRUI PHARMA Response to COVID-19 and Related Developments Table 93. Huadong Medicine Business Overview Table 94. Huadong Medicine Daptomycin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 95. Huadong Medicine Daptomycin Product Table 96. Huadong Medicine Response to COVID-19 and Related Developments Table 97. Daptomycin Distributors List Table 98. Daptomycin Customers List Table 99. Covid-19 Impact on Daptomycin Customers List of Figures Figure 1. Daptomycin Product Picture Figure 2. Daptomycin Market Segmentation Figure 3. Research Objectives Figure 4. Research Process Figure 5. Data Triangulation Figure 6. Research Approach Figure 7. Commodity Prices-Metals Price Indices Figure 8. Commodity Prices- Precious Metal Price Indices Figure 9. Commodity Prices- Agricultural Raw Material Price Indices Figure 10. Commodity Prices- Food and Beverage Price Indices Figure 11. Commodity Prices- Fertilizer Price Indices Figure 12. Commodity Prices- Energy Price Indices Figure 13. G20+: Economic Policy Responses to COVID-19 Figure 14. Global Daptomycin Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million) Figure 15. Global Daptomycin Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%) Figure 16. Global Daptomycin Market Size, Quarterly Growth, 2020-2021 (%) Figure 17. Global Daptomycin Market Size, Market Share by Type, 2019 VS 2020 (%) Figure 18. Global Daptomycin Market Size, Market Share by Application, 2019 VS 2020 (%) Figure 19. Global Daptomycin Market Size Market Share by Region, 2019 VS 2020 (%) Figure 20. United States Composite PMI and GDP Figure 21. Eurozone Composite PMI and GDP Figure 22. Eurozone Core v. Periphery PMI Output Indices Figure 23. Core v. Periphery PMI Employment Indices Figure 24. UK Composite PMI and GDP Figure 25. Caixin China Composite Output Index Figure 26. Caixin China General Services Business Activity Index Figure 27. Japan Composite Output Index Figure 28. South Korea Manufacturing PMI Figure 29. India Composite Output Index Figure 30. ASEAN Manufacturing PMI Figure 31. By Region, Asia-Pacific Daptomycin Market Size Market Share, 2019-2021

Merck & Co. Pfizer Teva Mylan Fresenius Kabi Sagent Pharmaceuticals Xellia Hisun HENGRUI PHARMA Huadong Medicine